PEDIATRICS Vol. 108 No. 1 July 2001, pp. 134-141
Outcome at 5 Years of Age of Children 23 to 27 Weeks' Gestation: Refining the Prognosis
From the Department of Obstetrics and Gynaecology, Royal
Women's Hospital, Carlton, Australia.
Objectives. To determine the changes
with postnatal age for survival, with and without major sensorineural
disability, to 5 years of age in very preterm infants and to contrast
their prognosis with normal birth weight (NBW) control participants.
Methods. A geographically determined cohort study was
conducted in Victoria, Australia. Consecutive live births of 23 to 27 weeks' gestational age born during 1991 to 1992 and randomly selected contemporaneous NBW control participants were studied. The main outcome
measures were survival and rates of major disability at 5 years of age,
determined for those offered intensive care, after day 7, after day 28, and at hospital discharge.
Results. Of 401 live births of 23 to 27 weeks' gestation,
225 (56.1%) survived to 5 years of age. The survival rate rose
significantly with increasing gestational age at birth in those offered
intensive care and by day 7 but not by day 28. The survival rate free
of major disability rose significantly with increasing gestational age
at all postnatal ages but was not an independent predictive variable by
day 28; other adverse events were more important. In the absence of
adverse events, the rate of survival free of major disability for very
preterm infants who had survived to discharge was 93.2%, similar to
the rate of 95.5% for NBW control participants.
Conclusions. The prognosis for very preterm infants
changes substantially with postnatal age. Counseling of families should
be repeated at intervals, and the advice offered should vary with
perinatal events.
![]()
ABSTRACT
Top
Abstract
Methods
Results
Discussion
Conclusion
References
When parents are counseled about the outcome for very
preterm children, they want to know not only whether their child will survive but also whether their child will survive with or without a
major sensorineural disability. The prognosis varies between regions1-10 and within regions,11
reflecting, in part, different attitudes toward treatment. Counseling
of parents has to reflect these regional differences. Certain variables
associated with adverse outcome, diagnosed at varying times, also will
influence the prognostication. However, exactly how perinatal events,
including attitudes toward treatment, interact to influence the
prognosis for very preterm infants is not well described. Moreover, to
know whether rates of problems are excessive or not, the outcome for
very preterm children has to be described relative to that for
nonpreterm or normal birth weight (NBW) control participants.
The aim of this study was to determine the changes in prognosis with
perinatal events, including postnatal age, for survival and for
survival with and without major sensorineural disability at 5 years of
age in very preterm infants 23 to 27 weeks' gestational age and to
contrast their prognosis with NBW control participants.
The very preterm cohort comprised 401 consecutive live-born
children at 23 to 27 completed weeks of gestational age in the 2-year
period from January 1, 1991, in Victoria, Australia. There were no
survivors born before 23 weeks of gestational age during this period.
Gestational age was calculated from dates obtained by menstrual
history, usually confirmed by ultrasound before 20 weeks' gestation.
Details of the multiple data sources used to determine survival were
reported previously.12
For children who were born outside level III perinatal centers and not
transferred after birth, only limited perinatal data (place of birth,
mode of delivery, gestational age, and birth weight) were obtained. For
the remaining children, more extensive perinatal data were
recorded.5 However, data on many perinatal variables still
were lacking for those who were born outside level III perinatal
centers and transferred after birth to level III centers. Some children
who were born in level III perinatal centers were not offered intensive
care either because they were considered too immature or because they
had lethal anomalies. Birth weight ratio was calculated by dividing the
child's weight by the median weight expected for gestational age and
gender of Australian children.13 Children with a birth
weight ratio <.80 were small for gestational age (SGA), and children with a birth weight ratio >1.25 were large for gestational age (LGA).
Cerebroventricular hemorrhage (CVH) was diagnosed during the first week
and graded according to Papile et al.14 Cystic
periventricular leukomalacia (PVL) was diagnosed before discharge and
defined as any cystic lesions developing in periventricular white
matter of the brain after birth. Postnatal corticosteroid therapy was
prescribed for some children after the first week, as described
elsewhere.15 Children who required surgery during the
primary hospitalization, mostly involving a general anesthetic but
occasionally a local anesthetic for minor surgery such as inguinal
hernia repair, were noted. Bronchopulmonary dysplasia (BPD) was
diagnosed in children with respiratory distress and an oxygen
requirement after 28 days of age.
Surviving children were enrolled in a longitudinal follow-up study of
growth and development. The NBW control participants comprised children
whose birth weights were >2499 g and who were randomly selected from
births in each of the 3 level III perinatal centers in Victoria and
matched with the preterm children for gender, health insurance status,
and mother's country of origin, as described elsewhere.5
Social class was determined by the occupation of the main income earner
in the family and dichotomized into higher (professional, skilled, and
semiskilled) and lower (unskilled or unemployed) classes. Informed,
written consent was obtained from the parents of the NBW control
participants but not the preterm cohort as follow-up was considered to
be part of their normal care. The study was approved by the Research
and Ethics Committees of the Royal Women's Hospital, Melbourne.
Details of the survival rates to 2 years of age for these children have
been reported.5 No child was known to have died between 2 and 5 years of age.
Surviving children were assessed at 5 years of age, corrected for
prematurity, by pediatricians and psychologists who were unaware of
perinatal details, as described elsewhere.15 The
psychological assessment included the Full, Verbal and Performance Scales of the Wechsler Preschool and Primary Scale of
Intelligence-Revised (WPPSI-R).16 Some children could
complete only 1 of the major subscales (Performance or Verbal) of the
WPPSI-R, either because English was not their primary language or
because of physical limitations. Several children were assessed with
alternative IQ tests when the WPPSI-R was unavailable, and that score
was taken to represent the child's IQ. Children who were untestable by
any psychological test because of severe intellectual impairment were assigned an IQ score of 40. Children had a major sensorineural disability if they had any of the following: blindness (bilateral vision worse than 6/60), sensorineural deafness requiring hearing aids,
cerebral palsy of such severity that the child was either not walking
or walking with considerable difficulty, or an IQ score < Data were edited and analyzed with the use of SPSS for Windows (version
9.0.1; SPSS Inc, Chicago, IL). Univariate analyses included
There were 401 consecutive live births with gestational ages 23 to
27 weeks, of whom 225 (56.1%) survived to 5 years of age. The survival
rate rose significantly with increasing gestational age (OR: 2.2; 95%
CI: 1.8, 2.6, for each week of increase in gestational age; Table
1). The survival rate for those born in a level III center was significantly higher than the survival rate for
those born outside a level III center (OR: 3.1; 95% CI: 1.6, 5.9, adjusted for gestational age). Of the 67 live births outside level III
centers, 57 were in level II hospitals (hospitals with obstetricians
and paediatricians available), 7 were in level I hospitals, and 3 were
outside any hospital.
TABLE 1
![]()
METHODS
Top
Abstract
Methods
Results
Discussion
Conclusion
References
2 SD below
the mean for the NBW control participants. Some children were not seen
at 5 years of age but had been evaluated at 2 years of
age.5 The status of these children with respect to major
sensorineural disability was assumed to be the same at 5 years of age,
and their results are included in this article.
2 tests for dichotomous variables and mean
differences and 95% confidence intervals (CIs) for normally
distributed continuous variables. To determine the significant
predictive variables, dichotomous outcomes were analyzed by forward
conditional logistic regression; odds ratios (ORs) and 95% CIs were
computed from the regression coefficients. Predictive variables were
added appropriate with the age at diagnosis; CVH from day 7 and
postnatal corticosteroid therapy, cystic PVL, surgery, and BPD from day
28. The logistic model was considered a good fit of the observed data
when the Hosmer-Lemeshow goodness-of-fit test17 was not
statistically significant. Predicted probabilities were computed for
individual children on the basis of their values for statistically
significant variables for 2 situations: 1) survival for infants offered
intensive care and 2) survival free of major disability for infants
discharged from the hospital. The predicted rates of outcomes computed
from logistic regression for subgroups of children with identical
predictive variables then were compared with the actual rates of each
outcome. Predicted probabilities were computed also for survival,
survival with no major disability, and survival with major disability
and plotted by both gestational age and postnatal age. The level of agreement in the classification of major disability in children in the
preterm group assessed at both 2 and 5 years of age was tested by the
Kappa statistic. Any bias in the estimate of disability was evaluated
by McNemar's test. For all tests, P < .05 was
considered statistically significant.
![]()
RESULTS
Top
Abstract
Methods
Results
Discussion
Conclusion
References
Survival Rate to 5 Years of Age for Live Births 23 to 27 Weeks'
Gestational Age by Place of Birth
Of the 176 preterm children who died, most (57%) did so on the first
day of life, with progressively diminishing proportions as postnatal
age increased (Table 2). First-day deaths were more frequent with lower gestational age. Of the 101 deaths on the
first day, 66 were not offered intensive care, including 36 infants who
were born outside a level III center and not transferred after birth.
Those who were not offered intensive care had significantly lower
gestational ages and birth weights than those who were offered intensive care (gestational age, weeks, mean difference:
2.0; 95%
CI:
2.3,
1.7; mean birth weight, g, mean difference:
238; 95%
CI:
283,
192). All infants who were born outside a level III center
and transferred did so on the first day of life; those who were not
transferred all died on the first day of life.
|
For infants who were offered intensive care on day 1, many perinatal variables differed significantly on univariate analysis between preterm children who died and those who survived (Table 3). On multivariate analysis, however, the only variables that were associated positively with survival were increasing maturity (OR for 1 week's increase: 1.8; 95% CI: 1.4, 2.2), antenatal corticosteroid therapy (OR: 1.9; 95% CI: 1.1, 3.2), being a multiple birth (OR: 2.1; 95% CI: 1.1, 3.7), being female (OR: 2.5; 95% CI: 1.5, 4.3), and not being SGA (OR: 7.4; 95% CI: 2.9, 18.4). As postnatal age increased, different variables were associated significantly with survival. Of note, antenatal corticosteroid therapy and multiple pregnancy were not important after day 1, and grade 3 or 4 CVH had an adverse association on day 7 only (OR: 0.22; 95% CI: 0.09, 0.55) but not by day 28. Gestational age was not important by 28 days of age. Being female and not being SGA had persistent survival advantages through each postnatal age (day 7 female OR: 3.3; 95% CI: 1.5, 7.3; not SGA OR: 3.3; 95% CI: 1.03, 10.4; day 28 female OR: 5.3; 95% CI: 1.5, 17.9; not SGA OR: 7.3; 95% CI: 1.8, 29.3). Postnatal steroid therapy, BPD, and surgery were not associated significantly with survival after adjustment for gender and SGA status.
|
For the combinations of perinatal variables in which the number of children in subgroups exceeded 15, the observed rates of survival in those who were offered intensive care, related to the presence or absence of adverse prognostic variables, were similar to those predicted from the logistic regression (Table 4).
|
Of the 265 NBW control participants in 1991 to 1992, 2 died before 5 years of age, 229 were assessed at 5 years of age, and data were available from formal developmental assessments at 2 years of age in another 16 children. The mean WPPSI-R Full Scale IQ was 105.8 (SD: 14.0) for the 222 NBW children who were able to complete the test at 5 years of age. Including an IQ of 40 for 2 untestable children and the results from the Performance Scale of the WPPSI-R for the other 5 children, the mean IQ score for the NBW control participants was 105.3 (SD: 15.1). Of the NBW control participants, none had cerebral palsy, blindness, or deafness; disability in the control participants, therefore, was assessed solely on the basis of psychological tests. A total of 10 of the 245 NBW control participants (4.1%; 95% CI: 2.0%, 7.4%) had a major sensorineural disability, and survival free of major sensorineural disability at 5 years was 95.5% (253 of 265; 95% CI: 92.2%, 97.6%) for those discharged from the hospital, assuming that the 18 children with no data did not have a disability.
Of the 225 preterm survivors to 5 years of age, outcome data were
available for 221 (98.2%), including 8 children assessed at 2 years of
age. Twenty-five of the 221 survivors (11.3%) assessed had some form
of cerebral palsy, but the disability was major only in 15. Four
children (1.8%) were blind, 2 children (0.9%) required hearing aids
for sensorineural deafness, and 34 children (15.4%) had IQ scores
<
2 SD compared with NBW control participants. In the preterm cohort,
44 of the 225 children (19.6%; 95% CI: 14.4%, 24.7%) had a major
sensorineural disability, assuming that the 4 survivors who were not
assessed had no disability. The rate of survival without a major
sensorineural disability for preterm infants discharged from the
hospital was 79.7% (181 of 227; 95% CI: 74.5%, 85.0%). The rate of
survival without major disability rose significantly with increasing
gestational age, with the denominator being any of all live births
(Table 2; OR for 1 week's increase: 2.18, 95% CI: 1.81, 2.63), live
births offered intensive care (OR for 1 week's increase: 1.75; 95%
CI: 1.42, 2.14), or those discharged from the hospital alive (Table 2;
OR for 1 week's increase: 1.63; 95% CI: 1.20, 2.20). Conversely, increasing gestational age was not related significantly to the rate of
survival with a major disability with the denominator either all live
births (Table 2; OR for 1 week's increase: 1.02; 95% CI: 0.81, 1.29)
or live births offered intensive care (OR for 1 week's increase: 0.78;
95% CI: 0.60, 1.02). Increasing gestational age was, however, related
significantly to a lower rate of survival with major disability in
survivors to hospital discharge (Table 2; OR for 1 week's increase:
0.59; 95% CI: 0.43, 0.80).
For children who were seen at 5 years of age, as expected there were many significant differences in perinatal variables between the preterm and NBW groups (Table 5). There were, however, no significant differences in gender or socioeconomic variables.
|
On multivariate analysis, the variables that were associated significantly with survival free of major sensorineural disability were similar to those associated with survival per se at each postnatal age through day 7, with the exceptions that surfactant was associated with a significant reduction in survival free of major disability at both day 1 (OR: 0.57; 95% CI: 0.35, 0.91) and day 7 (OR: 0.51; 95% CI: 0.29, 0.91), and multiple pregnancy was unimportant on day 1. However, by day 28, other events after birth became more important than those associated with survival per se: grade 3 or 4 CVH (OR: 0.29; 95% CI: 0.10, 0.85), cystic PVL (OR: 0.25; 95% CI: 0.08, 0.74), surgery during the primary hospitalization (OR: 0.34; 95% CI: 0.17, 0.67), and requiring postnatal corticosteroid therapy (OR: 0.23, 95% CI: 0.11, 0.45) were the only variables that were associated significantly with a lower rate of survival free of major sensorineural disability. In other words, these variables were associated positively with either death or disability.
The relationships between survival, survival free of major disability, and survival with major disability on the one hand and postnatal age and gestational age on the other hand are illustrated in Fig 1. The probability of survival rose progressively with increasing postnatal age (Fig 1A). The probability of survival rose significantly with increasing gestational age only for postnatal ages before day 28 (Fig 1A). The probability of survival without a major sensorineural disability rose significantly with increasing postnatal age (Fig 1B). The probability of survival without a major sensorineural disability rose significantly with increasing gestational age at all postnatal ages (Fig 1B). The probability of survival with a major disability was higher with increasing postnatal age (Fig 1C). The probability of survival with a major disability was not significantly negatively related to gestational age on day 1 but only on day 7 and day 28 (Fig 1C).
|
If children with no outcome data at either 2 or 5 years of age were
considered to have a disability or be dead, rather than without a
disability and alive, or if the analyses were limited to only those who
were assessed at 5 years of age, then few statistical conclusions were
altered. The minor exception was that antenatal steroid therapy was no
longer associated significantly with survival free of disability on day
1 (OR: 1.5; 95% CI: 0.92, 2.5). In the 210 children in the preterm
group who were assessed at both 2 and 5 years of age, the
classification of major disability or not was the same at both 2 and 5 years in 190 (90.5%). The level of agreement between the 2- and 5-year
assessments was highly significant (
= 0.691, t = 10.0, P
.0001). There was no significant bias in the
assessment of major disability at 2 years of age; disability at 5 years
of age was underestimated in 9 children and overestimated in 11 children at 2 years of age (McNemar test, P = .82, NS).
For preterm children who were discharged from the hospital, the adverse
prognostic variables that were associated significantly with survival
free of major disability at 5 years of age were grade 3 or 4 CVH (OR:
0.29; 95% CI: 0.10, 0.90), cystic PVL (OR: 0.24; 95% CI: 0.07, 0.74),
surgery during the primary hospitalization (OR: 0.35; 95% CI: 0.17, 0.67), and requiring postnatal corticosteroid therapy (OR: 0.26; 95%
CI: 0.12, 0.57). Almost one half had none of these adverse prognostic
variables, and their rate of survival free of major sensorineural
disability was 93.2% (Table 6), not
significantly different from the rate of 95.5% for NBW children (
2 = 0.6, NS). However, the rate of survival
free of major sensorineural disability fell as the number of adverse
prognostic variables increased (Table 6). The observed rates of
survival free of major sensorineural disability related to the number
of adverse prognostic variables were close to those predicted from the
logistic regression.
|
| |
DISCUSSION |
|---|
|
|
|---|
Although this study deals with <1% of all children born, they are the most controversial group with respect to active treatment. Attitudes toward their care differ; hence, their prognosis varies considerably between regions.1-10
The current study is geographically based, allowing the outcome for all very preterm children to be determined, not just those in perinatal centers that have selective referral patterns. Both survival and sensorineural disability are included, allowing an estimate of the interplay between these important events. Outcome has been determined at 5 years of age, enabling a more certain estimate of sensorineural morbidity than studies of outcome earlier in childhood. The follow-up rate is high, particularly for the preterm cohort, and therefore the uncertainty about children not assessed is reduced. There are contemporaneous NBW control participants with which to compare the outcome measures for very preterm children. The altered prognosis with changing events in the perinatal period has been estimated. No other study has been as rigorous in determining the prognosis for very preterm infants.
As well as some of the advantages of regional studies, listed above, there are limitations. We are less certain about care and decision making around the time of birth for infants who are born outside level III perinatal centers than we are within the 3 level III perinatal centers in Victoria. Most infants who were born outside level III centers were born in level II centers, with the ability to provide short-term assisted ventilation pending the arrival of the transport team. We also are unsure about the diagnosis of some other potentially important prognostic variables, such as chorioamnionitis and antepartum hemorrhage, in those born outside level III centers; hence, we could not include these variables in our analyses. Our data, however, might be considered as an estimate of the outcomes to be expected, averaged over other prognostic variables that could not be included because of lack of data. Another potential limitation of our study is that we included 2-year data on some children who were not assessed at 5 years of age. We also assumed that those with no follow-up data at all had no major disability, because this was the most likely outcome given the low rate of major disability, especially in the NBW control participants. Whether these children were included in analyses or not had little effect on the statistical conclusions of the study.
There has been increasing regionalization of perinatal intensive care in Victoria. Fewer very preterm or tiny children have been born outside level III perinatal centers over time; consequently, the survival difference between inborn and outborn children has widened.11 Lorenz18 recently reviewed the survival rates reported from 10 studies for extremely preterm infants born in North America in the 1990s. However, none of the studies quoted comprised a regional cohort and cannot be compared directly with our study. In several recent regional cohort studies reported from the United Kingdom,6,8,10 the survival rates have been similar to or lower than those in our study. The survival rate increased within our own region later in the 1990s.9 Possible reasons for differences in regional survival rates between the United Kingdom and Australia have been described elsewhere.9
Apart from place of birth and attitude toward treatment, in our study the other significant prognostic variables that were associated with improved survival in those who were offered intensive care were also reported by Draper et al8 (female gender, increasing gestational age, not being SGA, and multiple birth). In addition, antenatal corticosteroid therapy, not included by Draper et al,8 is known to improve survival rates in preterm infants.19 In our study, the importance of these prognostic variables changed with postnatal age. The effect of antenatal corticosteroids was obvious only early, whereas others (gender and SGA) persisted throughout the newborn period. The association of decreased survival of children who survived to day 7 with the presence of grade 3 or 4 CVH may reflect the degree of illness of some of these children or the withdrawal of intensive care in others. Interestingly, mother's race, birth weight, being LGA, and mode of delivery were not associated with improved survival after allowing for other, more important prognostic variables. There was, however, limited power to expect significant relationships with mother's race and being LGA. For more common combinations of significant prognostic variables, the probability of survival predicted from the logistic regression was close to the observed rates of survival. If these prognostic variables can be confirmed in an independent cohort, it means that prognostication can be refined further for infants with and without these characteristics. Draper at al8 provided outcomes for 2 time periods; first, for fetuses alive at labor onset, and second, for those admitted to neonatal units. The current study extends the time frame for prognostication at intervals from day 1 for those offered intensive care, up to the time of discharge home. Cooper et al20 described changes in survival rate with increasing postnatal age in very preterm infants. We extended these observations by also describing changes in sensorineural outcome with increasing postnatal age.
Several groups of investigators recently reported rates of sensorineural disabilities in regional cohorts of very preterm infants born in the 1990s. Tin et al6 reported that 27% of survivors (25 of 93) who were born at 23 to 27 weeks' gestational age in the Northern Region of England in 1991 to 1994 had a severe disability at 1 year of age, similar to the rate of major disability of 20% (44 of 225) in our study for children with the same gestational ages. More recently, the EPICure Study Group10 reported that 23% of survivors (64 of 283) who were born at 22 to 25 weeks' gestational age in the United Kingdom and Ireland in 1995 had a severe disability at 2.5 years of age, similar to the rate of major disability in our study of 29% (22 of 77) for survivors at 23 to 25 weeks' gestational age. It is difficult to make direct comparisons, however, as disabilities were not defined identically in all studies, and the ages of assessment also differed.
Early in the neonatal period, most of the variables that were associated with survival in our study also were associated with survival free of major sensorineural disability, because the number of children who died exceeded the number who survived with major disability. With increasing postnatal age, as the mortality rate dropped, the important prognostic variables that were associated with a lower rate of survival free of sensorineural disability were as expected, having been described elsewhere as being associated with adverse sensorineural outcome (CVH,21 PVL,21 postnatal corticosteroid therapy,15 and surgery during the primary hospitalization22). What is unique in the current study is an estimate of the additive contribution of these adverse variables on the rate of survival free of major sensorineural disability. Knowledge of the presence or absence of these variables during the primary hospitalization will facilitate counseling of parents whose children are being cared for in the nursery. Of note is that almost one half of very preterm survivors had no adverse prognostic variables, and their outcome was not significantly different from the contemporaneous NBW control participants. It also is noteworthy that at the time of deciding whether to offer intensive care, there is no clear relationship between survival with major disability and gestational age. For those who wish to avoid completely the birth of a infant who ultimately survives with a major disability, there is no gestational age, including term, that is totally free of that outcome. Indeed, at the time of initiating intensive care on day 1, the rate of survival with a major disability is the same at 23 weeks' gestation as it is in the NBW control participants, largely because most of those at 23 weeks ultimately die. Moreover, although the rate of disability in survivors to discharge falls with gestational age, there is no clear distinction between 23 and 26 weeks, inclusive. However, survivors at 27 weeks do almost as well as NBW control participants.
| |
CONCLUSION |
|---|
|
|
|---|
The prognosis for very preterm children varies with the place of birth (level III perinatal center or not), the attitude of both obstetricians and pediatricians toward care and hence the interventions they use, gestational age, postnatal age, and then later comorbidities. Because the prognosis changes substantially with postnatal age, counseling of families should be repeated at intervals, and the advice offered should vary with perinatal events.
| |
APPENDIX: PARTICIPANTS OF THE VICTORIAN INFANT COLLABORATIVE STUDY GROUP |
|---|
Convenor: Lex W. Doyle, MD, FRACP, pediatrician*. Collaborators
(in alphabetical order): Ellen Bowman, MB, BS, FRACP, pediatrician*¶; Catherine Callanan, RN, research nurse*; Elizabeth Carse, MB, BS,
FRACP, pediatrician§; Dan Casalaz, MB, BS, FRACP, pediatrician
; Margaret P. Charlton, MEd Psych, psychologist§; Noni Davis, MB, BS,
FRACP, pediatrician*; Geoffrey Ford, MB, BS, FRACP, pediatrician*; Simon Fraser, MB, BS, FRACP, pediatrician
; Jane Halliday, PhD, epidemiologist#, Marie Hayes, RN, research nurse§; Elaine Kelly, MA,
psychologist*
; Anne Rickards, PhD, psychologist*; Michael Stewart,
MB, BS, FRACP, pediatrician
; Andrew Watkins, MB, BS, FRACP,
pediatrician
; Heather Woods, RN, research nurse
; and Victor Yu,
MD, FRACP, pediatrician§.
From the *Royal Women's Hospital,
Mercy Hospital for Women,
§Monash Medical Centre,
Royal Children's Hospital, ¶Newborn Emergency Transport Service, and #Victorian Perinatal Data Collection Unit, Melbourne, Australia.
| |
ACKNOWLEDGMENT |
|---|
This study was funded in part by the Department of Human Services, Victoria, Australia.
| |
FOOTNOTES |
|---|
a See "Appendix" for a list of the Victorian Infant Collaborative Study Group participants.
Received for publication Sep 19, 2000; accepted Jan 16, 2001.
Address correspondence to (L.W.D.) Department of Obstetrics and Gynaecology, Royal Women's Hospital, 132 Grattan St, Carlton, Australia, 3053. E-mail: l.doyle{at}obgyn-rwh.unimelb.edu.au
| |
ABBREVIATIONS |
|---|
NBW, normal birth weight; SGA, small for gestational age; LGA, large for gestational age; CVH, cerebroventricular hemorrhage; PVL, periventricular leukomalacia; BPD, bronchopulmonary dysplasia; WPPSI-R, Wechsler Preschool and Primary Scale of Intelligence-Revised; CI, confidence interval; OR, odds ratio.
| |
REFERENCES |
|---|
|
|
|---|
- van Zeben-van der Aa TM, Verloove-Vanhorick SP, Brand R, Ruys JH Morbidity of very low birthweight infants at corrected age of 2 years in a geographically defined population. Lancet 1989; 1:253-255 [CrossRef][Medline]
-
Wariyar U,
Richmond S,
Hey E
Pregnancy outcome at 24-31 weeks'
gestation: neonatal survivors.
Arch Dis Child
1989;
64:678-686
[Abstract/Free Full Text] - Johnson A, Townshend P, Yudkin P, Bull D, Wilkinson AR Functional abilities at age 4 years of children born before 29 weeks of gestation. Br Med J 1993; 306:1715-1718
- Doyle LW, for the Victorian Infant Collaborative Study Group Outcome to five years of age of children born at 24-26 weeks' gestational age in Victoria. Med J Aust 1995; 163:11-14 [Medline]
- The Victorian Infant Collaborative Study Group Outcome at 2 years of children 23-27 weeks' gestation born in Victoria in 1991-92. J Paediatr Child Health. 1997; 33:161-165 [Medline]
-
Tin W,
Wariyar U,
Hey E
Changing prognosis for babies of less than 28 weeks' gestation in the north of England between 1983 and 1994. Northern Neonatal Network.
Br Med J
1997;
314:107-111
[Abstract/Free Full Text] - Cartlidge PH, Stewart JH Survival of very low birthweight and very preterm infants in a geographically defined population. Acta Paediatr 1997; 86:105-110 [Medline]
-
Draper ES,
Manktelow B,
Field DJ,
James D
Prediction of survival for
preterm births by weight and gestational age: retrospective population
based study.
Br Med J
1999;
319:1093-1097
[Abstract/Free Full Text] -
Doyle LW,
Morley CJ,
Halliday J
Prediction of survival for preterm
births. Data on the quality of survival are needed.
Br Med
J
2000;
320:648
[Free Full Text] -
Wood NS,
Marlow N,
Costeloe K,
Gibson AT,
Wilkinson AR,
for the EPICure
Study Group
Neurologic and developmental disability after extremely
preterm birth.
N Engl J Med
2000;
343:378-384
[Abstract/Free Full Text] - The Victorian Infant Collaborative Study Group Changing outcome for infants of birthweight 500-999 g born outside level-III centres in Victoria. Aust N Z J Obstet Gynaecol 1997; 37:253-257 [Medline]
- Doyle LW, Kitchen WH, Lumley J, Accuracy of mortality rates for livebirths 500-999 g birthweight [letter]. Med J Aust 1991; 156:72
- Beeby PJ, Bhutap T, Taylor LK New South Wales population-based birthweight percentile charts. J Paediatr Child Health 1996; 32:512-518 [Medline]
- Papile LA, Burstein J, Burstein R, Koffler H Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr 1978; 92:529-534 [CrossRef][Medline]
- The Victorian Infant Collaborative Study Group Postnatal corticosteroids and sensorineural outcome at 5 years of age. J Paediatr Child Health 2000; 36:256-261 [CrossRef][Medline]
- Wechsler D. Wechsler Preschool and Primary Scale of Intelligence-Revised. New York, NY: The Psychological Corporation; 1989
-
Lemeshow S,
Hosmer DW Jr
A review of goodness of fit statistics for
use in the development of logistic regression models.
Am J
Epidemiol
1982;
115:92-106
[Abstract/Free Full Text] - Lorenz JM Survival of the extremely preterm infant in North America in the 1990s. Clin Perinatol 2000; 27:255-262 [CrossRef][Medline]
- Crowley P. Corticosteroids prior to preterm delivery (Cochrane Review). In: The Cochrane Library, Issue 2. Oxford: Update Software; 1998. Updated quarterly
-
Cooper TR,
Berseth CL,
Adams JM,
Weisman LE
Actuarial survival in the
premature infant less than 30 weeks' gestation.
Pediatrics
1998;
101:975-978
[Abstract/Free Full Text] - Doyle LW, Betheras FR, Ford GW, Davis NM, Callanan C Survival, cranial ultrasound and cerebral palsy in very low birthweight infants: 1980s versus 1990s. J Paediatr Child Health 2000; 36:7-12 [CrossRef][Medline]
- The Victorian Infant Collaborative Study Group Surgery and the tiny baby: sensorineural outcome at 5 years of age. J Paediatr Child Health 1996; 32:167-172 [Medline]
Pediatrics (ISSN 0031 4005). Copyright ©2001 by the American Academy of Pediatrics
This article has been cited by other articles:
![]() |
A. I. Patrianakos-Hoobler, M. E. Msall, J. D. Marks, D. Huo, and M. D. Schreiber Risk Factors Affecting School Readiness in Premature Infants With Respiratory Distress Syndrome Pediatrics, July 1, 2009; 124(1): 258 - 267. [Abstract] [Full Text] [PDF] |
||||
![]() |
The EXPRESS Group One-Year Survival of Extremely Preterm Infants After Active Perinatal Care in Sweden JAMA, June 3, 2009; 301(21): 2225 - 2233. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Partridge, M. D. Sendowski, E. A. Drey, and A. M. Martinez Resuscitation of Likely Nonviable Newborns: Would Neonatology Practices in California Change if the Born-Alive Infants Protection Act Were Enforced? Pediatrics, April 1, 2009; 123(4): 1088 - 1094. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Madan, D. Kendrick, J. I. Hagadorn, I. D. Frantz III, and the National Institute of Child Health and Human D Patent Ductus Arteriosus Therapy: Impact on Neonatal and 18-Month Outcome Pediatrics, February 1, 2009; 123(2): 674 - 681. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Mangham, S. Petrou, L. W. Doyle, E. S. Draper, and N. Marlow The Cost of Preterm Birth Throughout Childhood in England and Wales Pediatrics, February 1, 2009; 123(2): e312 - e327. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Bassler, B. J. Stoll, B. Schmidt, E. V. Asztalos, R. S. Roberts, C. M. T. Robertson, R. S. Sauve, and for the Trial of Indomethacin Prophylaxis in Prete Using a Count of Neonatal Morbidities to Predict Poor Outcome in Extremely Low Birth Weight Infants: Added Role of Neonatal Infection Pediatrics, January 1, 2009; 123(1): 313 - 318. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bayless, I. M. Pit-ten Cate, and J. Stevenson Behaviour difficulties and cognitive function in children born very prematurely International Journal of Behavioral Development, May 1, 2008; 32(3): 199 - 206. [Abstract] [PDF] |
||||
![]() |
J. E. Tyson, N. A. Parikh, J. Langer, C. Green, R. D. Higgins, and the National Institute of Child Health and Human D Intensive Care for Extreme Prematurity -- Moving beyond Gestational Age N. Engl. J. Med., April 17, 2008; 358(16): 1672 - 1681. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Gianni, O. Picciolini, C. Vegni, L. Gardon, M. Fumagalli, and F. Mosca Twelve-Month Neurofunctional Assessment and Cognitive Performance at 36 Months of Age in Extremely Low Birth Weight Infants Pediatrics, November 1, 2007; 120(5): 1012 - 1019. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. T. Robertson, M.-J. Watt, and Y. Yasui Changes in the Prevalence of Cerebral Palsy for Children Born Very Prematurely Within a Population-Based Program Over 30 Years JAMA, June 27, 2007; 297(24): 2733 - 2740. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Chorne, C. Leonard, R. Piecuch, and R. I. Clyman Patent Ductus Arteriosus and Its Treatment as Risk Factors for Neonatal and Neurodevelopmental Morbidity Pediatrics, June 1, 2007; 119(6): 1165 - 1174. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Farooqi, B. Hagglof, G. Sedin, L. Gothefors, and F. Serenius Chronic Conditions, Functional Limitations, and Special Health Care Needs in 10- to 12-Year-Old Children Born at 23 to 25 Weeks' Gestation in the 1990s: A Swedish National Prospective Follow-up Study Pediatrics, November 1, 2006; 118(5): e1466 - e1477. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Janvier and K. J. Barrington Advocating for the Very Preterm Infant Pediatrics, July 1, 2006; 118(1): 429 - 430. [Full Text] [PDF] |
||||
![]() |
P.-Y. Ancel, F. Livinec, B. Larroque, S. Marret, C. Arnaud, V. Pierrat, M. Dehan, S. N'Guyen, B. Escande, A. Burguet, et al. Cerebral Palsy Among Very Preterm Children in Relation to Gestational Age and Neonatal Ultrasound Abnormalities: The EPIPAGE Cohort Study Pediatrics, March 1, 2006; 117(3): 828 - 835. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Mikkola, N. Ritari, V. Tommiska, T. Salokorpi, L. Lehtonen, O. Tammela, L. Paakkonen, P. Olsen, M. Korkman, V. Fellman, et al. Neurodevelopmental Outcome at 5 Years of Age of a National Cohort of Extremely Low Birth Weight Infants Who Were Born in 1996-1997 Pediatrics, December 1, 2005; 116(6): 1391 - 1400. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Darlow, J. L. Hutchinson, D. J. Henderson-Smart, D. A. Donoghue, J. M. Simpson, N. J. Evans, and on behalf of the Australian and New Zealand Neonat Prenatal Risk Factors for Severe Retinopathy of Prematurity Among Very Preterm Infants of the Australian and New Zealand Neonatal Network Pediatrics, April 1, 2005; 115(4): 990 - 996. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Blanco, G. Suresh, D. Howard, and R. F. Soll Ensuring Accurate Knowledge of Prematurity Outcomes for Prenatal Counseling Pediatrics, April 1, 2005; 115(4): e478 - e487. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Laptook, T. M. O' Shea, S. Shankaran, B. Bhaskar, and and the NICHD Neonatal Network Adverse Neurodevelopmental Outcomes Among Extremely Low Birth Weight Infants With a Normal Head Ultrasound: Prevalence and Antecedents Pediatrics, March 1, 2005; 115(3): 673 - 680. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Marlow, D. Wolke, M. A. Bracewell, M. Samara, and the EPICure Study Group Neurologic and Developmental Disability at Six Years of Age after Extremely Preterm Birth N. Engl. J. Med., January 6, 2005; 352(1): 9 - 19. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Msall Developmental Vulnerability and Resilience in Extremely Preterm Infants JAMA, November 17, 2004; 292(19): 2399 - 2401. [Full Text] [PDF] |
||||
![]() |
P. Anderson and L. W. Doyle Neurobehavioral Outcomes of School-age Children Born Extremely Low Birth Weight or Very Preterm in the 1990s JAMA, June 25, 2003; 289(24): 3264 - 3272. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Schmidt, E. V. Asztalos, R. S. Roberts, C. M. T. Robertson, R. S. Sauve, M. F. Whitfield, and for the Trial of Indomethacin Prophylaxis in Prete Impact of Bronchopulmonary Dysplasia, Brain Injury, and Severe Retinopathy on the Outcome of Extremely Low-Birth-Weight Infants at 18 Months: Results From the Trial of Indomethacin Prophylaxis in Preterms JAMA, March 5, 2003; 289(9): 1124 - 1129. [Abstract] [Full Text] [PDF] |
||||
![]() |
A E Cust, B A Darlow, and D A Donoghue Outcomes for high risk New Zealand newborn infants in 1998-1999: a population based, national study Arch. Dis. Child. Fetal Neonatal Ed., January 1, 2003; 88(1): F15 - 22. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. T. D'Angio, R. A. Sinkin, T. P. Stevens, N. K. Landfish, J. L. Merzbach, R. M. Ryan, D. L. Phelps, D. R. Palumbo, and G. J. Myers Longitudinal, 15-Year Follow-up of Children Born at Less Than 29 Weeks' Gestation After Introduction of Surfactant Therapy Into a Region: Neurologic, Cognitive, and Educational Outcomes Pediatrics, December 1, 2002; 110(6): 1094 - 1102. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. R. Ment, H. S. Bada, P. Barnes, P. E. Grant, D. Hirtz, L. A. Papile, J. Pinto-Martin, M. Rivkin, and T. L. Slovis Practice parameter: Neuroimaging of the neonate: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society Neurology, June 25, 2002; 58(12): 1726 - 1738. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||



· 







